BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24677002)

  • 1. Do blood groups have effect on prognosis of patients undergoing radical cystectomy?
    Süer E; Özcan C; Gökçe I; Gülpınar Ö; Göğüş C; Türkölmez K; Baltacı S; Bedük Y
    Int Urol Nephrol; 2014 Aug; 46(8):1521-6. PubMed ID: 24677002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.
    D'Andrea D; Moschini M; Soria F; Gust KM; Briganti A; Karakiewicz PI; Rouprêt M; Shariat SF
    Anticancer Res; 2017 Oct; 37(10):5747-5753. PubMed ID: 28982896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.
    Engel O; Soave A; Peine S; Kluth LA; Schmid M; Shariat SF; Dahlem R; Fisch M; Rink M
    World J Urol; 2015 Nov; 33(11):1769-76. PubMed ID: 25782867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
    Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
    Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution.
    Moschini M; Bianchi M; Rossi MS; Dell׳Oglio P; Gandaglia G; Fossati N; Mattei A; Damiano R; Shariat SF; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    Urol Oncol; 2016 Jun; 34(6):256.e7-256.e13. PubMed ID: 26850780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Gershman B; Moreira DM; Tollefson MK; Frank I; Cheville JC; Thapa P; Tarrell RF; Thompson RH; Boorjian SA
    Urol Oncol; 2016 Jan; 34(1):4.e1-9. PubMed ID: 26329815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radical cystectomy in patients with pathological non-muscle invasive bladder cancer].
    Hao H; Su XH; Zheng W; Ge P; He Q; Shen Q; Yang XY; Zhang Z; Li XS; Lin J; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):627-631. PubMed ID: 29263502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.
    Tarin TV; Power NE; Ehdaie B; Sfakianos JP; Silberstein JL; Savage CJ; Sjoberg D; Dalbagni G; Bochner BH
    Eur Urol; 2012 May; 61(5):1025-30. PubMed ID: 22342773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
    BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of survival in infiltrating urothelial bladder carcinoma. A retrospective study of 158 patients treated by radical cystectomy].
    Thieblemont C; Fendler JP; Trillet-Lenoir V; Petris C; Chauvin F; Brunat-Mentigny M; Devaux Y; Devonec M; Gérard JP; Perrin P
    Bull Cancer; 1996 Feb; 83(2):139-46. PubMed ID: 8652908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Klatte T; Xylinas E; Rieken M; Rouprêt M; Fajkovic H; Seitz C; Karakiewicz PI; Lotan Y; Babjuk M; de Martino M; Shariat SF
    Urol Oncol; 2014 Jul; 32(5):625-30. PubMed ID: 24495451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients.
    Zhang ZL; Dong P; Li YH; Liu ZW; Yao K; Han H; Qin ZK; Zhou FJ
    Chin J Cancer; 2014 Mar; 33(3):165-71. PubMed ID: 23958053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.